A clinical trial to learn more about the effects of remibrutinib (LOU064) in people with papulopustular rosacea

Authors
Category Primary study
Registry of TrialsClinical Trials Information System
Year 2026
This article has no abstract
Epistemonikos ID: 9c4d00eca04f5fc7f9de948a8434c9cb6e63b6ba
First added on: Oct 15, 2026